Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
8.19
-0.23 (-2.73%)
At close: Nov 7, 2025, 4:00 PM EST
8.19
0.00 (0.00%)
After-hours: Nov 7, 2025, 4:00 PM EST
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $597.77 million as of November 7, 2025. Its market cap has increased by 79.55% in one year.
Market Cap
597.77M
Enterprise Value
483.46M
1-Year Change
79.55%
Ranking
Category
Stock Price
$8.19
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $597.77M, an increase of 120.29%. That is a compound annual growth rate of 48.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 586.22M | 169.34% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |